BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 27857177)

  • 1. miR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer.
    Hong Y; Liang H; Uzair-Ur-Rehman ; Wang Y; Zhang W; Zhou Y; Chen S; Yu M; Cui S; Liu M; Wang N; Ye C; Zhao C; Liu Y; Fan Q; Zhang CY; Sang J; Zen K; Chen X
    Sci Rep; 2016 Nov; 6():37421. PubMed ID: 27857177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling.
    Du WW; Fang L; Li M; Yang X; Liang Y; Peng C; Qian W; O'Malley YQ; Askeland RW; Sugg SL; Qian J; Lin J; Jiang Z; Yee AJ; Sefton M; Deng Z; Shan SW; Wang CH; Yang BB
    J Cell Sci; 2013 Mar; 126(Pt 6):1440-53. PubMed ID: 23418360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-21: A gene of dual regulation in breast cancer.
    Zhang C; Liu K; Li T; Fang J; Ding Y; Sun L; Tu T; Jiang X; Du S; Hu J; Zhu W; Chen H; Sun X
    Int J Oncol; 2016 Jan; 48(1):161-72. PubMed ID: 26549725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-613 promotes cell proliferation and invasion in cervical cancer via targeting PTPN9.
    Li WT; Wang BL; Yang CS; Lang BC; Lin YZ
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4107-4114. PubMed ID: 30024598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
    Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
    Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-106b targets FUT6 to promote cell migration, invasion, and proliferation in human breast cancer.
    Li N; Liu Y; Miao Y; Zhao L; Zhou H; Jia L
    IUBMB Life; 2016 Sep; 68(9):764-75. PubMed ID: 27519168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA SNHG7 contributes to tumorigenesis and progression in breast cancer by interacting with miR-34a through EMT initiation and the Notch-1 pathway.
    Sun X; Huang T; Liu Z; Sun M; Luo S
    Eur J Pharmacol; 2019 Aug; 856():172407. PubMed ID: 31132353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
    Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4.
    Zhao L; Feng X; Song X; Zhou H; Zhao Y; Cheng L; Jia L
    Oncol Rep; 2016 Aug; 36(2):1007-15. PubMed ID: 27375041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
    Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
    Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1.
    Liu DZ; Chang B; Li XD; Zhang QH; Zou YH
    Clin Transl Oncol; 2017 Sep; 19(9):1133-1140. PubMed ID: 28397066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
    Li N; Miao Y; Shan Y; Liu B; Li Y; Zhao L; Jia L
    Cell Death Dis; 2017 May; 8(5):e2796. PubMed ID: 28518139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-494 inhibits breast cancer progression by directly targeting PAK1.
    Zhan MN; Yu XT; Tang J; Zhou CX; Wang CL; Yin QQ; Gong XF; He M; He JR; Chen GQ; Zhao Q
    Cell Death Dis; 2017 Jan; 8(1):e2529. PubMed ID: 28055013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
    Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
    Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2.
    Zhang Y; Xu G; Liu G; Ye Y; Zhang C; Fan C; Wang H; Cai H; Xiao R; Huang Z; Luo Q
    Biochem Biophys Res Commun; 2016 Aug; 476(4):607-613. PubMed ID: 27264952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA-106a Promotes Breast Cancer Cell Proliferation, Clonogenicity, Migration, and Invasion Through Inhibiting Apoptosis and Chemosensitivity.
    You F; Luan H; Sun D; Cui T; Ding P; Tang H; Sun D
    DNA Cell Biol; 2019 Feb; 38(2):198-207. PubMed ID: 30570350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Critical Role of the miR-21-MEG2 Axis in Colorectal Cancer.
    Bao Z; Gao S; Zhang B; Shi W; Li A; Tian Q
    Crit Rev Eukaryot Gene Expr; 2020; 30(6):509-518. PubMed ID: 33463918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-105-3p acts as an oncogene to promote the proliferation and metastasis of breast cancer cells by targeting GOLIM4.
    Lin B; Liu C; Shi E; Jin Q; Zhao W; Wang J; Ji R
    BMC Cancer; 2021 Mar; 21(1):275. PubMed ID: 33722196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.